55
Superluminal Medicines, Inc. raises $65.5M under Reg D
Company raise · Closed · Offering $65.5M · Sold $65.5M · BOSTON, MA · filed 2026-09-03
45
Superluminal Medicines, Inc. raises $5M under Reg D
Company raise · Closed · BOSTON, MA · Form D filed 2025-08-26
First raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| DYLAN MORRIS | Director |
| ANDREW LEVIN | Director |
| DIAMANTIS XYLAS | Director |
| CONY D'CRUZ | Executive Officer, Director, Promoter |
Signed by Cony DCruz, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.